Article
Optimization of In vivo Imaging Provides a First Look at Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD) Using Intravital Microscopy.
Frontiers in immunology - 1 Jan 2019
Davis Rachelle P, Surewaard Bas G J, Turk Madison, Carestia Agostina, Lee Woo-Yong, Petri Björn, Urbanski Stefan J, Coffin Carla S, Jenne Craig N
Abstract excerpt
Non-alcoholic fatty liver disease is a spectrum of liver pathology ranging from simple steatosis to steatohepatitis and can progress to diseases associated with poor outcomes including cirrhosis and hepatocellular carcinoma (HCC). NAFLD research has typically focused on the pathophysiology associated with lipid metabolism, using traditional measures such as histology and serum transaminase assessment; these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
